×
About 190,765 results

ALLMedicine™ Glucose Center

Research & Reviews  66,220 results

Butein-Enriched Fractions of Butea monosperma (Lam.) Taub. Flower Decrease Weight Gains...
https://doi.org/10.1089/jmf.2021.K.0074
Journal of Medicinal Food; Jang J, Chang SH et. al.

Dec 2nd, 2021 - Butea monosperma (Lam.) Taub. has been applied to treat inflammatory, metabolic, and infectious diseases. However, the antiobesity effects of B. monosperma (Lam.) Taub. flower (BMF) and the underlying mechanisms have not been determined. In this s...

Inverse correlation between serum irisin and cardiovascular risk factors among Chinese ...
https://doi.org/10.1186/s12872-021-02380-0
BMC Cardiovascular Disorders; Liu R, Zhang Q et. al.

Dec 2nd, 2021 - Irisin is a novel myokine associated with obesity, which is a traditional cardiovascular risk factor (CVRF). The present study aimed to investigate the association between serum irisin and a single CVRF as well as the clustering of CVRFs among Chi...

Investigation of In-vitro Efficacy of Intravenous Fosfomycin in Extensively Drug-Resist...
https://doi.org/10.1016/j.ijantimicag.2021.106489
International Journal of Antimicrobial Agents; Aydemir Ö, Şahin EÖ et. al.

Dec 2nd, 2021 - This study aimed to determine the in vitro efficacy of IV fosfomycin against extensively drug-resistant Enterobacterales strains and the effect of glucose 6-phosphate on sensitivity results. Thirty-two extensively drug-resistant Klebsiella pneumon...

Suppressive Effects of Anisomycin on the Proliferation of B16 Mouse Melanoma Cells In V...
https://doi.org/10.21873/anticanres.15431
Anticancer Research; Ushijima H, Monzaki R et. al.

Dec 2nd, 2021 - Anisomycin, a potential anticancer therapeutic drug, exerts an antitumor effect on melanoma cells at a lower concentration than that required for other cancer cells. However, the molecular mechanisms remain unclear. The sensitivity to and cytotoxi...

see more →

Guidelines  45 results

Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021.
https://doi.org/10.1016/j.jcjd.2021.07.003
Canadian Journal of Diabetes; , Cheng AYY et. al.

Sep 14th, 2021 - Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021.|2021| ,Cheng AYY,Feig DS,Ho J,Siemens R,|

Glucose management for exercise using continuous glucose monitoring (CGM) and intermitt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702152
Pediatric Diabetes; Moser O, Riddell MC et. al.

Oct 14th, 2020 - Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and d...

Walking for subjects with type 2 diabetes: A systematic review and joint AMD/SID/SISMES...
https://doi.org/10.1016/j.numecd.2020.08.021
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Moghetti P, Balducci S et. al.

Oct 2nd, 2020 - Regular exercise is considered a cornerstone in the management of type 2 diabetes mellitus (T2DM). It improves glucose control and cardiovascular risk factors, contributes to weight loss, and also improves general well-being, likely playing a role...

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-base...
https://doi.org/10.1016/j.kint.2020.06.024
Kidney International; de Boer IH, Caramori ML et. al.

Jul 13th, 2020 - Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease represents the first KDIGO guideline on this subject. The guideline comes at a time when advances in diabetes technology and therapeuti...

Diabetes at the front door. A guideline for dealing with glucose related emergencies at...
https://doi.org/10.1111/dme.14304
Diabetic Medicine : a Journal of the British Diabetic Ass... Dhatariya K, James J et. al.

Apr 13th, 2020 - People with diabetes account for nearly one-fifth of all inpatients in English and Welsh hospitals; of these, up to 90% are admitted as an emergency. Most are admitted for a reason other than diabetes with only 8% requiring admission for a diabete...

see more →

Drugs  312 results see all →

Clinicaltrials.gov  3,920 results

Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices
https://clinicaltrials.gov/ct2/show/NCT05124405

Nov 26th, 2021 - Primary objective: To evaluate the feasibility of a CGM-based physical activity intervention that includes the use of CGM and Fitbit®. Secondary objectives: To examine changes in physical activity motivation and other related psychosocial variable...

Postprandial Responses to Hydroxytyrosol-enriched Bread
https://clinicaltrials.gov/ct2/show/NCT04725955

Nov 25th, 2021 - The amelioration of postprandial glucose and insulin responses to bread is of great importance since it may have significant beneficial effects on health. A number of studies have shown that hydroxytyrosol may have positive metabolic effects. Howe...

Application of Magnesium-rich Artificial Cerebrospinal Fluid in Aneurysmal Subarachnoid Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT04358445

Nov 25th, 2021 - From now on, participants who meet the inclusion and exclusion criteria in our hospital will be recruited in the intervention group, if they and their relatives are willing to join in the study. For the historical control group, in which patients ...

ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
https://clinicaltrials.gov/ct2/show/NCT05134662

Nov 25th, 2021 - This is a Phase 1, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of ALT-801 and its effects on glucose control in overweight and obese su...

Time in Glucose Hospital Target
https://clinicaltrials.gov/ct2/show/NCT05135676

Nov 25th, 2021 - Protocol Overview: The glucose management team (GMT) at each site will identify potentially eligible patients. After informed consent and confirmation of eligibility, each participant will be randomly assigned to the Standard Target or Intensive T...

see more →

News  5,746 results

FDA OKs First Drug for Aggressive, Ultra-Rare Sarcoma
https://www.medpagetoday.com/hematologyoncology/othercancers/95831

Nov 23rd, 2021 - The FDA approved nab-sirolimus (Fyarro) on Tuesday for the treatment of malignant perivascular epithelioid cell tumors (PEComa), a rare and aggressive form of sarcoma. Nab-sirolimus, an albumin-bound mTOR inhibitor, is indicated for patients with ...

Case: Older patient with T2D has recurrent flushing
https://www.mdedge.com/internalmedicine/article/248875/geriatrics/case-older-patient-t2d-has-recurrent-flushing
Douglas S. Paauw, MD

Nov 18th, 2021 - A 64 year-old man with type 2 diabetes complains of recurrent flushing for the past 6 months. He has had no other symptoms.

Continuous Ketone Monitoring Has Potential to Cut DKA in Diabetes
https://www.medscape.com/viewarticle/963120

Nov 17th, 2021 - The development of an on-body continuous ketone monitor (CKM) is seen as potentially helpful for the prevention of diabetic ketoacidosis (DKA) and other clinical situations. Speakers at two meetings held this month have addressed the potential use...

Canagliflozin Improves HF Symptoms in Fully Remote Trial
https://www.medscape.com/viewarticle/963094

Nov 16th, 2021 - New research shows that the benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors on symptoms and quality of life in patients with heart failure extend to canagliflozin (Invokana, Invokamet, Janssen). Canagliflozin 100 mg daily bested plac...

Finerenone, Sotagliflozin Benefit HF Despite Renal Dysfunction
https://www.medscape.com/viewarticle/962945

Nov 15th, 2021 - New analyses of trial results for the cardiorenal agents finerenone and sotagliflozin continued the pattern showing that they exert consistent heart failure benefits in patients who span a broad spectrum of renal function, further disproving the n...

see more →

Patient Education  63 results see all →